Skip to content

Non-invasive Brain Stimulation for the Treatment of Psychiatric Disorders

Non-invasive Brain Stimulation for the Treatment of Psychiatric Disorders

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01872143
Enrollment
100
Registered
2013-06-07
Start date
2013-05-31
Completion date
2014-05-31
Last updated
2013-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Disorders

Brief summary

The purpose of this study is to determine whether transcranial direct current stimulation (tDCS) is effective in the treatment of psychiatric disorders in which available treatments are either ineffective or not tolerated

Detailed description

Depending on the specific psychiatric disorder, inhibitory or stimulating neuromodulation will be applied over the cortical region of interest, found according to the relevant scientific publication on neurophysiology of psychiatric disorders

Interventions

DEVICEtranscranial Direct Current Stimulation

daily or twice-a-day administration of transcranial Direct Current Stimulation from a minimum of 10 session to a maximum of 20

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* a psychiatric disorder in which available treatment are either ineffective or not tolerated

Exclusion criteria

* implantable active devices

Design outcomes

Primary

MeasureTime frame
Change from Baseline Psychiatric rating scales scores at immediate post-treatment and at one-month and at three-month follow-up visitsTime points: T0=baseline; T1=immediate post-treatment; T2=one-month follow-up visit; T3=3-months follow-up visit

Countries

Italy

Contacts

Primary Contactgiordano d'urso, MD, PhD
giordanodurso@me.com+390817462652

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026